Global View Capital Management’s Eli Lilly LLY Stock Holding History

Global View Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$504K	Buy	420 +33	+9%	+$33.7K	0.1%	84
2026 Q1	$356K	Sell	387 -216	-36%	-$219K	0.09%	103
2025 Q4	$648K	Buy	603 +67	+13%	+$64.1K	0.12%	70
2025 Q3	$409K	Buy	536 +31	+6%	+$23.1K	0.09%	89
2025 Q2	$394K	Sell	505 -12	-2%	-$9.32K	0.13%	78
2025 Q1	$427K	Sell	517 -26	-5%	-$21.6K	0.16%	73
2024 Q4	$422K	Buy	+543	New	+$450K	0.15%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Global View Capital Management's LLY Position: Q2 2026 in Review

Global View Capital Management increased its Eli Lilly (LLY) stake by 8.5% in Q2 2026, buying an estimated $33.7K and bringing the position to 420 shares worth $504K. The position accounts for 0.1% of the portfolio, ranked #84.

Global View Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $648K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Global View Capital Management held 420 shares of Eli Lilly worth $504K as of Q2 2026.
Global View Capital Management bought 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
Eli Lilly made up 0.1% of Global View Capital Management's portfolio in Q2 2026, its #84 holding.
Global View Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
Global View Capital Management's Eli Lilly position peaked at $648K in Q4 2025.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Global View Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.